BCL2L1 and head and neck squamous cell carcinoma: We also show that SCCHN is dependent on both BCL-XL and MCL-1 for survival, which can be efficiently targeted to induce marked apoptosis and tumor shrinkage, suggesting that a combination BH3 mimetic therapy may offer significant benefits in SCCHN.